Health Official Tries to Reassure Public That Science Will Set Vaccine Approval Dr. Francis S. Collins, the National Institutes of Health director, who testified before senators along with Surgeon General Jerome Adams, said a vaccine wouldn’t be made available unless it was safe. Vaccine politics demand more from big pharmaThe FDA usually wants high standards while drugmakers push boundaries. But political pressure and public unease over a rushed process has forced a role reversal. Trump puts pressure on FDA for coronavirus silver bullet ahead of Election DayFacing a persistent polling deficit and a struggling economy, President Donald Trump has cranked up pressure on administration health officials to expedite work both on a coronavirus vaccine and on treatments that might signal to voters there is an end in Trump fixates on the promise of a vaccine — real or not — as key to reelection bidThe campaign gambit is aimed at improving his standing with an electorate that overwhelmingly disapproves of his management of the pandemic. White House faces skepticism over prospects for a coronavirus vaccineCould the U.S. really see a coronavirus vaccine before Election Day? A letter from federal health officials instructing states to be ready to begin distrib Top health officials pledge to keep politics out of COVID-19 vaccine processTop federal health officials tried to reassure lawmakers on Wednesday that politics will not play a role in determining whether a COVID-19 vaccine is approved, amid fears that President Trump is politicizing the process. Drug companies seek to reassure public amid Trump vaccine pushDrug companies are seeking to reassure the public that coronavirus vaccine approval will be based on science, not politics, as the push for a vaccine intensifies and President Trump floats the idea of pre-Election Day approval. Top drugmakers made a rare joint pledge not to cut corners on the coronavirus vaccine amid fears shots are being rushed before the presidential electionPresident Trump has said a vaccine would probably be available for distribution next month — despite experts saying it could take until 2021.